Scholarly Index
Kevan M. Shokat
University of California, San Francisco; 53,877 total citations; 416 total publications; best world rank #2
University of California, San Francisco
53,877Total citations
416Total publications
114H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| PI3K/AKT/mTOR signaling in cancer | Lifetime | 27 | US 16 | 99.68 |
| Protein Kinase Regulation and GTPase Signaling | Lifetime | 73 | US 46 | 99.35 |
| Protein Degradation and Inhibitors | Lifetime | 88 | US 51 | 99.20 |
| Biochemical and Molecular Research | Lifetime | 133 | US 82 | 98.74 |
| Monoclonal and Polyclonal Antibodies Research | Lifetime | 600 | US 329 | 98.99 |
| Click Chemistry and Applications | Lifetime | 249 | US 96 | 98.18 |
| Ubiquitin and proteasome pathways | Lifetime | 413 | US 207 | 98.15 |
| Chronic Lymphocytic Leukemia Research | Lifetime | 694 | US 320 | 98.28 |
| Melanoma and MAPK Pathways | Lifetime | 200 | US 108 | 97.74 |
| Signaling Pathways in Disease | Lifetime | 371 | US 192 | 96.13 |
| 14-3-3 protein interactions | Lifetime | 115 | US 56 | 94.25 |
| Protein Kinase Regulation and GTPase Signaling | 2021-2025 | 2 | US 2 | 98.90 |
| PI3K/AKT/mTOR signaling in cancer | 2021-2025 | 30 | US 20 | 94.88 |
| Biochemical and Molecular Research | 2021-2025 | 142 | US 29 | 85.94 |
| Signaling Pathways in Disease | 2021-2025 | 118 | US 35 | 79.80 |
| Cancer-related Molecular Pathways | 2021-2025 | 422 | US 155 | 82.82 |
| Enzyme Structure and Function | 2021-2025 | 931 | US 293 | 70.91 |